HHSC Sets Clinical Prior Authorization Implementation Dates This Spring HHSC will implement the following clinical prior authorizations for clients enrolled in Medicaid fee-for-service in the weeks ahead: Calcitonin Gene-Related Peptide Receptor Antagonists (April 4) Antimigraine Agents (Triptans) (April 4) Inhaled Antibiotics (May 2) Sodium-glucose linked transporter-2 (SGLT-2) Agents (May 2) Hyperlipidemia Agents (May 2) Juxtapid criteria Zelboraf (May 2)

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202